1
|
South AM, Giammattei VC, Bagley KW, Bakhoum CY, Beasley WH, Bily MB, Biswas S, Bridges AM, Byfield RL, Campbell JF, Chanchlani R, Chen A, D'Agostino McGowan L, Downs SM, Fergeson GM, Greenberg JH, Hill-Horowitz TA, Jensen ET, Kallash M, Kamel M, Kiessling SG, Kline DM, Laisure JR, Liu G, Londeree J, Lucas CB, Mannemuddhu SS, Mao KR, Misurac JM, Murphy MO, Nugent JT, Onugha EA, Pudupakkam A, Redmond KM, Riar S, Sethna CB, Siddiqui S, Thumann AL, Uss SR, Vincent CL, Viviano IV, Walsh MJ, White BD, Woroniecki RP, Wu M, Yamaguchi I, Yun E, Weaver DJ. The Study of the Epidemiology of Pediatric Hypertension Registry (SUPERHERO): rationale and methods. Am J Epidemiol 2024; 193:1650-1661. [PMID: 38881045 PMCID: PMC11637526 DOI: 10.1093/aje/kwae116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2023] [Revised: 04/29/2024] [Accepted: 06/07/2024] [Indexed: 06/18/2024] Open
Abstract
Despite increasing prevalence of hypertension in youth and high adult cardiovascular mortality rates, the long-term consequences of youth-onset hypertension remain unknown. This is due to limitations of prior research, such as small sample sizes, reliance on manual record review, and limited analytic methods, that did not address major biases. The Study of the Epidemiology of Pediatric Hypertension (SUPERHERO) is a multisite, retrospective registry of youth evaluated by subspecialists for hypertension disorders. Sites obtain harmonized electronic health record data using standardized biomedical informatics scripts validated with randomized manual record review. Inclusion criteria are index visit for International Classification of Diseases, 10th Revision (ICD-10) code-defined hypertension disorder on or after January 1, 2015, and age < 19 years. We exclude patients with ICD-10 code-defined pregnancy, kidney failure on dialysis, or kidney transplantation. Data include demographics, anthropomorphics, US Census Bureau tract, histories, blood pressure, ICD-10 codes, medications, laboratory and imaging results, and ambulatory blood pressure. SUPERHERO leverages expertise in epidemiology, statistics, clinical care, and biomedical informatics to create the largest and most diverse registry of youth with newly diagnosed hypertension disorders. SUPERHERO's goals are to reduce CVD burden across the life course and establish gold-standard biomedical informatics methods for youth with hypertension disorders.
Collapse
Affiliation(s)
- Andrew M South
- Section of Nephrology, Department of Pediatrics, Wake Forest University School of Medicine, Winston Salem, NC 27157, United States
- Department of Epidemiology and Prevention, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, NC 27157, United States
- Center for Artificial Intelligence Research, Wake Forest University School of Medicine, Winston Salem, NC 27157, United States
| | - Victoria C Giammattei
- Section of Nephrology, Department of Pediatrics, Wake Forest University School of Medicine, Winston Salem, NC 27157, United States
| | - Kiri W Bagley
- Section of Nephrology, Department of Pediatrics, Wake Forest University School of Medicine, Winston Salem, NC 27157, United States
| | - Christine Y Bakhoum
- Section of Nephrology, Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06519, United States
| | - William H Beasley
- Developmental and Behavioral Pediatrics, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, United States
| | - Morgan B Bily
- Division of Nephrology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States
| | - Shupti Biswas
- Department of Pediatrics, Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New Hyde Park, NY 11040, United States
| | - Aaron M Bridges
- Center for Artificial Intelligence Research, Wake Forest University School of Medicine, Winston Salem, NC 27157, United States
- Clinical and Translational Science Institute, Wake Forest University School of Medicine, Winston Salem, NC 27157, United States
| | - Rushelle L Byfield
- Division of Nephrology and Hypertension, Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, United States
| | - Jessica Fallon Campbell
- Division of Nephrology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States
| | - Rahul Chanchlani
- Division of Nephrology, Department of Pediatrics, McMaster University, Hamilton, ON L8N 1H4, Canada
| | - Ashton Chen
- Section of Nephrology, Department of Pediatrics, Wake Forest University School of Medicine, Winston Salem, NC 27157, United States
| | - Lucy D'Agostino McGowan
- Department of Statistical Sciences, Wake Forest University, Winston Salem, NC 27157, United States
| | - Stephen M Downs
- Department of Pediatrics-General, Wake Forest University School of Medicine, Winston Salem, NC 27157, United States
| | - Gina M Fergeson
- Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, United States
| | - Jason H Greenberg
- Section of Nephrology, Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06519, United States
| | - Taylor A Hill-Horowitz
- Division of Nephrology, Department of Pediatrics, Cohen Children’s Medical Center, Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY 11040, United States
| | - Elizabeth T Jensen
- Department of Epidemiology and Prevention, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, NC 27157, United States
| | - Mahmoud Kallash
- Division of Nephrology and Hypertension, Department of Pediatrics, Ohio State College of Medicine, Columbus, OH 43205, United States
| | - Margret Kamel
- Division of Nephrology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, United States
| | - Stefan G Kiessling
- Division of Nephrology, Department of Pediatrics, University of Kentucky College of Medicine, Lexington, KY 40506, United States
| | - David M Kline
- Department of Biostatistics and Data Science, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, NC 27157, United States
| | - John R Laisure
- Section of Nephrology, Department of Pediatrics, Wake Forest University School of Medicine, Winston Salem, NC 27157, United States
| | - Gang Liu
- Division of Pediatric Research, Department of Pediatrics, Atrium Health Levine Children's, Charlotte, NC 28207, United States
| | - Jackson Londeree
- Division of Nephrology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, United States
| | - Caroline B Lucas
- Section of Nephrology, Department of Pediatrics, Wake Forest University School of Medicine, Winston Salem, NC 27157, United States
| | - Sai Sudha Mannemuddhu
- Division of Pediatric Nephrology, East Tennessee Children's Hospital, University of Tennessee at Knoxville, Knoxville, TN 37916, United States
| | - Kuo-Rei Mao
- IS Enterprise Reporting, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, United States
| | - Jason M Misurac
- Division of Nephrology, Dialysis, and Transplantation, Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, IA 52242, United States
| | - Margaret O Murphy
- Division of Nephrology, Department of Pediatrics, University of Kentucky College of Medicine, Lexington, KY 40506, United States
| | - James T Nugent
- Section of Nephrology, Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06519, United States
| | - Elizabeth A Onugha
- Division of Nephrology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States
| | - Ashna Pudupakkam
- Division of Nephrology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States
| | - Kathy M Redmond
- Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, United States
| | - Sandeep Riar
- Division of Nephrology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, United States
| | - Christine B Sethna
- Division of Nephrology, Department of Pediatrics, Cohen Children’s Medical Center, Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY 11040, United States
| | - Sahar Siddiqui
- Division of Nephrology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States
| | - Ashley L Thumann
- General and Community Pediatrics, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, United States
| | - Stephen R Uss
- Yale Center for Clinical Investigation, Yale University School of Medicine, New Haven, CT 06519, United States
| | - Carol L Vincent
- Section of Nephrology, Department of Pediatrics, Wake Forest University School of Medicine, Winston Salem, NC 27157, United States
| | - Irina V Viviano
- Center for Artificial Intelligence Research, Wake Forest University School of Medicine, Winston Salem, NC 27157, United States
- Clinical and Translational Science Institute, Wake Forest University School of Medicine, Winston Salem, NC 27157, United States
| | - Michael J Walsh
- Section of Cardiology, Department of Pediatrics, Wake Forest University School of Medicine, Winston Salem, NC 27157, United States
| | - Blanche D White
- Division of Nephrology and Hypertension, Department of Pediatrics, Atrium Health Levine Children's, Charlotte, NC 28203, United States
| | - Robert P Woroniecki
- Division of Nephrology, Department of Pediatrics, Stony Brook Medicine, Stony Brook, NY 11794, United States
| | - Michael Wu
- McMaster University School of Medicine, Hamilton, ON L8N 1H4, Canada
| | - Ikuyo Yamaguchi
- Department of Pediatrics, Division of Nephrology, University of Oklahoma College of Medicine, Oklahoma City, OK 73104, United States
| | - Emily Yun
- Division of Nephrology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, United States
| | - Donald J Weaver
- Division of Nephrology and Hypertension, Department of Pediatrics, Atrium Health Levine Children's, Charlotte, NC 28203, United States
| |
Collapse
|
2
|
Martinez F, Redon J, Aguilar F, Calderon JM, Lurbe E. Persistence and determinants of blood pressure phenotypes according to office and ambulatory blood pressure measurements in youth. Hypertens Res 2023; 46:1257-1266. [PMID: 36635525 DOI: 10.1038/s41440-022-01159-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2022] [Revised: 12/07/2022] [Accepted: 12/12/2022] [Indexed: 01/14/2023]
Abstract
Ambulatory BP monitoring is increasingly used in children and adolescents, and the persistence of discrepant phenotypes, such as white coat or masked hypertension, is a relevant issue. The objective of this study was to assess the persistence of BP phenotypes over time and the factors related to their persistence. The study included 582 children and adolescents (9.4 ± 2.8 years of age) of both sexes (51% females) referred for routine health maintenance. Anthropometric parameters and office and 24-h ABPM measurements were obtained twice (interval 19.5 ± 6.9 months). BP classification and phenotypes were qualified using the 2016 ESH Guidelines. The correlation coefficient and kappa statistics were used to assess the persistence of phenotypes, and the related factors were evaluated using logistic regression. Based on both systolic and diastolic BP measurements, 91.6%, 16%, 17.2% and 13.7% of the subjects with true normotension, sustained HTN, white coat HTN and masked HTN, respectively, remained in the same category (overall agreement 74.2%, kappa 0.20). The multivariate model predicted the lack of persistence and correctly classified 90.3% of the subjects, with the pathological baseline BP phenotype (mainly masked HTN) being the independent variable that contributed most to the model. Excluding the phenotypes, the rest of the model explained 14% of the lack of persistence, and a high office SBP and high waist circumference were related to the lack of persistence. Furthermore, subjects who experienced an increase in their BMI z score and change in their BMI category were at risk of a lack of persistence. In conclusion, children, especially those with BP phenotypes different from true normotension, should be re-evaluated because a large percentage are likely to become normotensive.
Collapse
Affiliation(s)
- Fernando Martinez
- Cardiovascular and Renal Research Group, INCLIVA Research Institute, University of Valencia, Valencia, Spain.,Internal Medicine Hospital Clínico of Valencia, Valencia, Spain
| | - Josep Redon
- Cardiovascular and Renal Research Group, INCLIVA Research Institute, University of Valencia, Valencia, Spain.,CIBER Fisiopatologia Obesidad y Nutricion, Instituto de Salud Carlos III, Madrid, Spain
| | - Francisco Aguilar
- CIBER Fisiopatologia Obesidad y Nutricion, Instituto de Salud Carlos III, Madrid, Spain.,Pediatric Department, Consorcio Hospital General, University of Valencia, Valencia, Spain
| | - José Miguel Calderon
- Pediatric Department, Consorcio Hospital General, University of Valencia, Valencia, Spain
| | - Empar Lurbe
- CIBER Fisiopatologia Obesidad y Nutricion, Instituto de Salud Carlos III, Madrid, Spain. .,Pediatric Department, Consorcio Hospital General, University of Valencia, Valencia, Spain.
| |
Collapse
|
3
|
Kovács B, Németh Á, Daróczy B, Karányi Z, Maroda L, Diószegi Á, Nádró B, Szabó T, Harangi M, Páll D. Determining the prevalence of childhood hypertension and its concomitant metabolic abnormalities using data mining methods in the Northeastern region of Hungary. Front Cardiovasc Med 2023; 9:1081986. [PMID: 36704476 PMCID: PMC9871628 DOI: 10.3389/fcvm.2022.1081986] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2022] [Accepted: 12/22/2022] [Indexed: 01/12/2023] Open
Abstract
Objective Identifying hypertension in children and providing treatment for it have a marked impact on the patients' long-term cardiovascular outcomes. The global prevalence of childhood hypertension is increasing, yet its investigation has been rather sporadic in Eastern Europe. Therefore, our goal was to determine the prevalence of childhood hypertension and its concomitant metabolic abnormalities using data mining methods. Methods We evaluated data from 3 to 18-year-old children who visited the University of Debrecen Clinical Center's hospital throughout a 15-year study period (n = 92,198; boys/girls: 48/52%). Results We identified a total of 3,687 children with hypertension (2,107 boys and 1,580 girls), with a 4% calculated prevalence of hypertension in the whole study population and a higher prevalence in boys (4.7%) as compared to girls (3.2%). Among boys we found an increasing prevalence in consecutive age groups in the study population, but among girls the highest prevalences are identified in the 12-15-year age group. Markedly higher BMI values were found in hypertensive children as compared to non-hypertensives in all age groups. Moreover, significantly higher total cholesterol (4.27 ± 0.95 vs. 4.17 ± 0.88 mmol/L), LDL-C (2.62 ± 0.79 vs. 2.44 ± 0.74 mmol/L) and triglyceride (1.2 (0.85-1.69) vs. 0.94 (0.7-1.33) mmol/L), and lower HDL-C (1.2 ± 0.3 vs. 1.42 ± 0.39 mmol/L) levels were found in hypertensive children. Furthermore, significantly higher serum uric acid levels were found in children with hypertension (299.2 ± 86.1 vs. 259.9 ± 73.3 μmol/L), while glucose levels did not differ significantly. Conclusion Our data suggest that the calculated prevalence of childhood hypertension in our region is comparable to data from other European countries and is associated with early metabolic disturbances. Data mining is an effective method for identifying childhood hypertension and its metabolic consequences.
Collapse
Affiliation(s)
- Beáta Kovács
- Division of Metabolic Disorders, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
| | - Ákos Németh
- Division of Metabolic Disorders, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
| | - Bálint Daróczy
- Institute for Computer Science and Control, Eötvös Loránd Research Network (ELKH SZTAKI), Budapest, Hungary,Université catholique de Louvain, INMA, Louvain-la-Neuve, Belgium
| | - Zsolt Karányi
- Division of Metabolic Disorders, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
| | - László Maroda
- Department of Medical Clinical Pharmacology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
| | - Ágnes Diószegi
- Division of Metabolic Disorders, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
| | - Bíborka Nádró
- Division of Metabolic Disorders, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
| | - Tamás Szabó
- Department of Pediatrics, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
| | - Mariann Harangi
- Division of Metabolic Disorders, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
| | - Dénes Páll
- Department of Medical Clinical Pharmacology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary,*Correspondence: Dénes Páll,
| |
Collapse
|
4
|
Lurbe E, Mancia G, Calpe J, Drożdż D, Erdine S, Fernandez-Aranda F, Hadjipanayis A, Hoyer PF, Jankauskiene A, Jiménez-Murcia S, Litwin M, Mazur A, Pall D, Seeman T, Sinha MD, Simonetti G, Stabouli S, Wühl E. Joint statement for assessing and managing high blood pressure in children and adolescents: Chapter 1. How to correctly measure blood pressure in children and adolescents. Front Pediatr 2023; 11:1140357. [PMID: 37138561 PMCID: PMC10150446 DOI: 10.3389/fped.2023.1140357] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/08/2023] [Accepted: 03/13/2023] [Indexed: 05/05/2023] Open
Abstract
The joint statement is a synergistic action between HyperChildNET and the European Academy of Pediatrics about the diagnosis and management of hypertension in youth, based on the European Society of Hypertension Guidelines published in 2016 with the aim to improve its implementation. The first and most important requirement for the diagnosis and management of hypertension is an accurate measurement of office blood pressure that is currently recommended for screening, diagnosis, and management of high blood pressure in children and adolescents. Blood pressure levels should be screened in all children starting from the age of 3 years. In those children with risk factors for high blood pressure, it should be measured at each medical visit and may start before the age of 3 years. Twenty-four-hour ambulatory blood pressure monitoring is increasingly recognized as an important source of information as it can detect alterations in circadian and short-term blood pressure variations and identify specific phenotypes such as nocturnal hypertension or non-dipping pattern, morning blood pressure surge, white coat and masked hypertension with prognostic significance. At present, home BP measurements are generally regarded as useful and complementary to office and 24-h ambulatory blood pressure for the evaluation of the effectiveness and safety of antihypertensive treatment and furthermore remains more accessible in primary care than 24-h ambulatory blood pressure. A grading system of the clinical evidence is included.
Collapse
Affiliation(s)
- Empar Lurbe
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
- Department of Pediatric, Consorcio Hospital General, University of Valencia, Valencia, Spain
- Correspondence: Empar Lurbe Elke Wühl Adamos Hadjipanayis
| | | | | | - Dorota Drożdż
- Department of Pediatric Nephrology and Hypertension, Pediatric Institute, Jagiellonian University Medical College, Kraków, Poland
| | - Serap Erdine
- Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Istanbul, Turkey
| | - Fernando Fernandez-Aranda
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
- University Hospital of Bellvitge-IDIBELL, Barcelona, Spain
- Department of Clinical Sciences, University of Barcelona, Barcelona, Spain
| | - Adamos Hadjipanayis
- School of Medicine, European University Cyprus, Nicosia, Cyprus
- Department of Paediatrics, Larnaca General Hospital, Larnaca, Cyprus
- Correspondence: Empar Lurbe Elke Wühl Adamos Hadjipanayis
| | - Peter F. Hoyer
- Department of Pediatrics II, University Hospital Essen, Essen, Germany
| | - Augustina Jankauskiene
- Pediatric Center, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania
| | - Susana Jiménez-Murcia
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
- University Hospital of Bellvitge-IDIBELL, Barcelona, Spain
- Department of Clinical Sciences, University of Barcelona, Barcelona, Spain
| | - Mieczysław Litwin
- Department of Nephrology, Kidney Transplantation and Hypertension, The Children's Memorial Health Institute, Warsaw, Poland
| | - Artur Mazur
- Institute of Medical Sciences, Medical College, Rzeszów University, Rzeszow, Poland
| | - Denes Pall
- Department of Medical Clinical Pharmacology, University of Debrecen, Debrecen, Hungary
- Department of Medicine, University of Debrecen, Debrecen, Hungary
| | - Tomas Seeman
- Division of Pediatric Nephrology, University Children’s Hospital, Charles University, Prague, Czechia
- Department of Pediatrics, University Hospital Ostrava, Ostrava, Czechia
| | - Manish D. Sinha
- Department of Paediatric Nephrology, Evelina London Children's Hospital, Guy's and St Thomas’ NHS Foundation Trust, London, United Kingdom
| | - Giacomo Simonetti
- Institute of Pediatrics of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland
| | - Stella Stabouli
- 1st Department of Pediatrics, Aristotle University of Thessaloniki, Hippokratio General Hospital of Thessaloniki, Thessaloniki, Greece
| | - Elke Wühl
- Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany
- Correspondence: Empar Lurbe Elke Wühl Adamos Hadjipanayis
| |
Collapse
|
5
|
Sun X, Liu Y, Liu Y, Wang H, Liu B, Shi L. Association between red blood cell distribution width and left ventricular hypertrophy in pediatric essential hypertension. Front Pediatr 2023; 11:1088535. [PMID: 36816384 PMCID: PMC9932496 DOI: 10.3389/fped.2023.1088535] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/03/2022] [Accepted: 01/09/2023] [Indexed: 02/05/2023] Open
Abstract
AIM Left ventricular hypertrophy (LVH) is one of the most common types of target organ damage in hypertension. The red blood cell distribution width (RDW) is closely related to many cardiovascular diseases, including hypertension. The aim of this study was to analyze the relationship between the RDW level and LVH in pediatric essential hypertension. MATERIALS AND METHODS A total of 429 untreated children and adolescents with essential hypertension were recruited and divided into an LVH group (n = 114) and non-LVH group (n = 315) according to left ventricular mass index (LVMI) and relative wall thickness (RWT) by color Doppler ultrasound. Spearman correlation analysis was used to determine the relationship between RDW and LVMI, RWT. The effect of RDW on LVH was determined using a multivariate logistic regression analysis. To assess the predictive value of RDW on LVH, the receiver operating characteristic (ROC) curve was used. RESULTS The level of RDW in children with hypertension in the LVH group was significantly higher than that in the non-LVH group (13.0 [12.0, 13.0] vs. 12.4 [12.0, 13.0] %, P = 0.001). The incidence of low and high quantiles of LVH was 21.0% and 32.0%, respectively. Spearman correlation analysis showed that RDW was positively correlated with C-reactive protein (CRP), LVMI, RWT, and red blood cell (RBC) count (P all < 0.05), and negatively correlated with hemoglobin (HGB) level, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC) (P all < 0.05). After adjusting for various confounding factors, a multivariate logistic regression model revealed that RDW was an independent risk factor for LVH (OR = 1.946, 95% CI: 1.324-2.861, P = 0.001). The area under the ROC curve of RDW predicting centripetal hypertrophy was 0.700 (95% CI: 0.541-0.859, P < 0.05) in pediatric essential hypertension. CONCLUSIONS Increased RDW levels are an independent risk factor for LVH in pediatric essential hypertension, and RDW may be a predictor of LVH in untreated pediatric essential hypertension.
Collapse
Affiliation(s)
- Xiaodong Sun
- Capital Institute of Pediatrics, Beijing, China.,Department of Cardiology, Children's Hospital, Capital Institute of Pediatrics, Beijing, China
| | - Yang Liu
- Department of Cardiology, Children's Hospital, Capital Institute of Pediatrics, Beijing, China
| | - Yanyan Liu
- Department of Cardiology, Children's Hospital, Capital Institute of Pediatrics, Beijing, China
| | - Hui Wang
- Department of Cardiology, Children's Hospital, Capital Institute of Pediatrics, Beijing, China
| | - Bo Liu
- Department of Cardiology, Children's Hospital, Capital Institute of Pediatrics, Beijing, China
| | - Lin Shi
- Capital Institute of Pediatrics, Beijing, China.,Department of Cardiology, Children's Hospital, Capital Institute of Pediatrics, Beijing, China
| |
Collapse
|
6
|
South AM, Allen NB. Antenatal Programming of Hypertension: Paradigms, Paradoxes, and How We Move Forward. Curr Hypertens Rep 2022; 24:655-667. [PMID: 36227517 PMCID: PMC9712278 DOI: 10.1007/s11906-022-01227-z] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/28/2022] [Indexed: 01/31/2023]
Abstract
PURPOSE OF REVIEW Synthesize the clinical, epidemiological, and preclinical evidence for antenatal programming of hypertension and critically appraise paradigms and paradoxes to improve translation. RECENT FINDINGS Clinical and epidemiological studies persistently demonstrate that antenatal factors contribute to programmed hypertension under the developmental origins of health and disease framework, including lower birth weight, preterm birth, and fetal growth restriction. Preclinical mechanisms include preeclampsia, maternal diabetes, maternal undernutrition, and antenatal corticosteroid exposure. However, clinical and epidemiological studies to date have largely failed to adequately identify, discuss, and mitigate many sources and types of bias in part due to heterogeneous study designs and incomplete adherence to scientific rigor. These limitations have led to incomplete and biased paradigms as well as persistent paradoxes that have significantly limited translation into clinical and population health interventions. Improved understanding of these paradigms and paradoxes will allow us to substantially move the field forward.
Collapse
Affiliation(s)
- Andrew M South
- Department of Pediatrics, Section of Nephrology, Brenner Children's, Wake Forest University School of Medicine, One Medical Center Boulevard, Winston-Salem, NC, 27157, USA.
- Division of Public Health Sciences, Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
- Department of Surgery-Hypertension and Vascular Research, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
- Cardiovascular Sciences Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
| | - Norrina B Allen
- Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| |
Collapse
|
7
|
Kapur G, Stenson AF, Chiodo LM, Delaney-Black V, Hannigan JH, Janisse J, Ratner HH. Childhood Violence Exposure Predicts High Blood Pressure in Black American Young Adults. J Pediatr 2022; 248:21-29.e1. [PMID: 35660017 DOI: 10.1016/j.jpeds.2022.05.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/14/2021] [Revised: 05/19/2022] [Accepted: 05/24/2022] [Indexed: 11/26/2022]
Abstract
OBJECTIVE To test the impact of childhood adversity, including community violence exposure, on hypertension risk in Black American young adults to understand what risk factors (eg, prenatal factors, later exposures) and ages of adversity exposure increased hypertension risk. STUDY DESIGN The study included 396 Black American participants with data from prenatal, birth, and age 7-, 14-, and 19-year visits. At age 19 years, individuals with blood pressure (BP) measures >120 mmHg systolic and/or >80 mmHg diastolic were classified as having high blood pressure (HBP), and those with BP <120/80 mmHg were classified as normal. Associations between prenatal and birth risk factors; childhood adversity at age 7, 14, and 19 years; age 19 body mass index (BMI); and both systolic and diastolic BP at age 19 were tested using logistic regression models. RESULTS Age 19 BMI was positively associated with systolic and diastolic HBP status at age 19. Controlling for all covariates, community violence exposure at age 7 and 19 years was associated with 2.2-fold (95% CI, 1.242-3.859) and 2.0-fold (95% CI, 1.052-3.664) greater odds of systolic HBP, respectively, at age 19 years. Prenatal risk, birth risk, and other dimensions of childhood adversity were not associated with HBP in this cohort. CONCLUSION Childhood community violence exposure is a significant risk factor for HBP in young adults. As Black American children typically experience more community violence exposure than other American children, our results suggest that racial disparities in childhood community violence exposure may contribute to racial disparities in adult hypertension burden.
Collapse
Affiliation(s)
- Gaurav Kapur
- Department of Pediatrics, Wayne State University, Detroit, MI; Department of Pediatrics, Central Michigan University, Mount Pleasant, MI
| | - Anaïs F Stenson
- Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, MI.
| | - Lisa M Chiodo
- College of Nursing, University of Massachusetts-Amherst, Amherst, MA
| | | | - John H Hannigan
- Department of Obstetrics & Gynecology, Wayne State University, Detroit, MI; C.S. Mott Center for Human Growth & Development, Wayne State University, Detroit, MI; Merrill-Palmer Skillman Institute for Child & Family Development, Wayne State University, Detroit, MI; Center for Urban Responses to Environmental Stressors, Wayne State University, Detroit, MI; Department of Psychology, Wayne State University, Detroit, MI
| | - James Janisse
- Department of Family Medicine & Public Health Sciences, Wayne State University, Detroit, MI
| | - Hilary H Ratner
- Merrill-Palmer Skillman Institute for Child & Family Development, Wayne State University, Detroit, MI; Department of Psychology, Wayne State University, Detroit, MI
| |
Collapse
|
8
|
Lurbe E, Redon J, Alvarez J, Grau-Pérez M, Martinez F, Mancia G. Insights From Matched Office and Ambulatory Blood Pressure in Youth: Clinical Relevance. Hypertension 2022; 79:1237-1246. [PMID: 35345885 DOI: 10.1161/hypertensionaha.122.18993] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND Information on the relationship between ambulatory blood pressure (ABP) and concurrently office blood pressure (BP) values in youth still suffers from limitations. We provide information on the differences between office BP and ABP, the factors related, and the clinical implications. METHODS Three thousand six hundred ninety matched measurements of office BP and ABP on the same day, from 2390 children, aged 5 to 15 years, of both sexes were eligible. Office BP was measured using an oscillometric device (Omron 705 IT) and 24-hour ABP using oscillometric SpaceLabs 90207. Average of office, 24-hour, daytime, nighttime, systolic, and diastolic BP and heart rate was calculated. BP categories according to the European guidelines and phenotype of mismatch office BP versus ABP were defined. RESULTS Both daytime systolic and diastolic BP were higher than office BP with a progressive reduction of the differences from 5 to 15 years. The office minus daytime BP differences were the largest in normotensive subjects, less at high-normal, and reversed in hypertensive ones, independently of age and weight status. White coat and masked hypertension covered no more than 13.6% at all ages. CONCLUSIONS In youth, it is inaccurate to obtain reference values for ABP by extrapolating from office BP values. The differences between office BP and ABP are minimal in children with office BP values in the range of hypertension, reinforcing the recommendation to use ABP measurement at the time to confirm hypertension.
Collapse
Affiliation(s)
- Empar Lurbe
- Pediatric Department, Consorcio Hospital General (E.L., J.A.), University of Valencia, Spain.,Centro de Investigación Biomédica en Red Fisiopatología Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain (E.L., J.R., J.A.)
| | - Josep Redon
- Cardiovascular and Renal Research Group, INCLIVA Research Institute (J.R., M.G.-P., F.M.), University of Valencia, Spain.,Centro de Investigación Biomédica en Red Fisiopatología Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain (E.L., J.R., J.A.)
| | - Julio Alvarez
- Pediatric Department, Consorcio Hospital General (E.L., J.A.), University of Valencia, Spain.,Centro de Investigación Biomédica en Red Fisiopatología Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain (E.L., J.R., J.A.)
| | - Maria Grau-Pérez
- Cardiovascular and Renal Research Group, INCLIVA Research Institute (J.R., M.G.-P., F.M.), University of Valencia, Spain
| | | | | |
Collapse
|